课题基金 / 基金详情

Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop

Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
动脉老化的进展:局部 MCP-1/MMP-2/TGF-beta 1 信号环路
批准号:
7963894
负责人:
Mingyi Wang
金额:
$33.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Mingyi Wang的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this study, dual staining shows that MCP-1 and TGF-beta1, a powerful profibrogenic cytokine, markedly increases and co-localizes within the aortic wall in the thickened, intima of rats, nonhuman primates, and humans with aging. Cardiovascular signaling network analysis indicates that MCP-1 interacts with TGF-beta1. and is centrally located and directly connected with the inflammation cascade, which is closely associated with MMP-2 activation. In vitro study shows that MCP-1 elevates MMP2, a known activator of latent TGF-beta1 in a dose- or time-dependent manner through CCR-2 signaling in cultured VSMC from young (8 mo) rat aortae, reaching the levels of old cells (30mo). MCP-1 treatment increases activated intracellular and extracellular TGF-beta1 and its downstream molecules collagen types I and III, which is dependent upon MMP-2 activation in young VSMC, reaching levels of untreated old cells. Furthermore, cellular activated TGF-beta1nis distributed and increased in VSMC subfractions, including cytosol, the organelles and the nuclei, with aging. Interestingly, knockdown of MCP-1 via siRNA or overexpression of ectopic TIMP-2 by adenovirus transfection reduces activation of MMP-2 and TGF-beta1 and production of collagen type I and III in old VSMC. Moreover, MCP-1 treatment enhances the invasive capacity of young cells in an MMP-2 activation-dependent manner, resembling that of untreated old cells. These effects are substantially reduced by both CCR-2 and an MMP inhibitor, GM 6001. Of note, TGF-beta1 treatment increases MCP-1, MMP-2, and VSMC invasiveness in a dose-dependent manner in young VSMC, up to levels of old untreated cells. Taken together, this complex local signaling loop of MCP-1/MMP-2/TGF-beta1 plays a bedrock role in the initiation and progression of age-associated arterial intimal cellularity and fibrosis. Interruption of this vicious cycle is a potential therapeutic approach to arterial health in the elderly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
  • 批准号:
    7732171
  • 项目类别:
  • 资助金额:
    $26.56万
  • 财政年份:
    --
  • 负责人:
    Mingyi Wang
  • 依托单位:
Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
  • 批准号:
    8736500
  • 项目类别:
  • 资助金额:
    $44.05万
  • 财政年份:
    --
  • 负责人:
    Mingyi Wang
  • 依托单位:
Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
  • 批准号:
    8156756
  • 项目类别:
  • 资助金额:
    $32.21万
  • 财政年份:
    --
  • 负责人:
    Mingyi Wang
  • 依托单位:
Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
  • 批准号:
    8552341
  • 项目类别:
  • 资助金额:
    $45.86万
  • 财政年份:
    --
  • 负责人:
    Mingyi Wang
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: